Magnesium intervention during pregnancy

Acid-base balance and blood pressure during pregnancy: a double-blinded randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN98365455

Enrollment

Registered

2010-09-14

Start date

2010-10-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Pregnancy and Childbirth

Interventions

Magnesium citrate powder (Diasporal), 12 mmol magnesium daily, taken at week 25 of pregnancy until delivery. Control group receive no supplements. Blood pressure and proteinurea are measured routinely

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. First time pregnancies 2. Urinary calcium excretion in excess of 6 mmol around pregnancy week 20

Exclusion criteria

Exclusion criteria: History of blood pressure or renal dysfunction

Design outcomes

Primary

Measure	Time frame
Blood pressure increase during final weeks of pregnancy	—

Secondary

Measure	Time frame
Symptoms of pre-eclampsia during final weeks of pregnancy	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026